I-metastatic renal cell carcinoma

I-Metastatic renal cell carcinoma (mRCC) luhlobo lomhlaza wezintso othe wanwenwela kwamanye amalungu omzimba. Iinketho zonyango ziyahluka ngokuxhomekeke kwinqanaba kunye neempawu ezithile zomhlaza, kodwa zihlala zibandakanya unyango olujoliswe kuyo, i-immunotherapy, utyando, kunye nonyango lwemitha. Ukufunyaniswa kwangethuba kunye neendlela ezintsha zonyango zibalulekile ekuphuculeni iziphumo kwizigulana ezine-mRCC. Esi sikhokelo sinika inkcazo enzulu ye-mRCC, equka oonobangela bayo, iimpawu, ukuxilongwa, iindlela zonyango, kunye noxilongo.Yintoni iRenal Cell Carcinoma kunye neMetastasis?Renal cell carcinoma (RCC) lolona hlobo luxhaphakileyo lomhlaza wezintso kubantu abadala. Isuka kwinwebu yeproximal convoluted tubule, iityhubhu ezincinci kwizintso ezihluza igazi kwaye zisuse inkunkuma. Xa i-RCC i-metastasizes, ithetha ukuba iiseli zomhlaza ziye zaqhekeka kwi-tumor yasekuqaleni kwizintso kwaye zasasazeka kwezinye iindawo zomzimba, njengemiphunga, amathambo, ingqondo, okanye isibindi. Yakuba isasazekile, ihlelwa njenge I-metastatic renal cell carcinoma (mRCC) Ukutyeba ngokugqithisileyo: Ukutyeba kakhulu okanye ukutyeba kunxulunyaniswa nomngcipheko owongezelelekileyo. Uxinzelelo lwegazi oluphezulu: Uxinzelelo lwegazi olungapheliyo lungonakalisa izintso kwaye lwandise umngcipheko womhlaza. Imbali yoSapho: Ukuba nembali yosapho lwe-RCC kwandisa umngcipheko wakho. Iimeko ezithile ezizuzwe njengelifa, ezifana nesifo se-von Hippel-Lindau (VHL), i-Birt-Hogg-Dube syndrome, kunye ne-hereditary papillary renal cell carcinoma, zidibene nomngcipheko ophezulu. Isifo sezintso eziPhezulu okanye i-Dialysis: Abantu abanesifo esingapheliyo sezintso, ngakumbi abo baphantsi kwe-dialysis, banomngcipheko okhulayo. Ukutyhileka kwiMichiza ethile: Ukuchayeka emsebenzini kwi-cadmium, i-trichlorethylene, kunye nezinye ii-herbicides ziye zadityaniswa ne-RCC. Njengoko i-tumor ikhula okanye i-metastasizes, iimpawu zinokuvela. Ezi zinokwahluka ngokuxhomekeke apho umhlaza usasazeke khona, kodwa iimpawu eziqhelekileyo ze I-metastatic renal cell carcinoma zibandakanya: Igazi kumchamo (hematuria) Intlungu eqhubekayo ecaleni okanye ngasemva Igaqa okanye ubunzima kwicala okanye umva Ukulahleka kobunzima obungachazwanga Ukudinwa Umkhuhlane ongabangelwa sisifo I-anemia (inani eliphantsi leeseli ezibomvu zegazi) Iintlungu zamathambo (ukuba umhlaza usasazeke emathanjeni) Ukudumba emaqatheni nasemilenzeniUkuxilongwa kweMetastatic Renal Cell. I-metastatic renal cell carcinoma ngokwesiqhelo kubandakanya indibaniselwano yeemviwo zomzimba, iimvavanyo zokucinga, kunye ne-biopsies. Uviwo lwePhysical Exam: Ugqirha uya kwenza uvavanyo lomzimba ukujonga nakuphi na ukungaqhelekanga. Iimvavanyo ze-Imaging: I-CT Scan: I-CT scan inikeza imifanekiso ecacileyo yezintso kunye nezicubu ezijikelezileyo kwaye inokunceda ukufumanisa i-tumor kunye nokuvavanya ubukhulu kunye nendawo. I-MRI: I-MRI inokubonelela ngemifanekiso eneenkcukacha ngakumbi kwaye ihlala isetyenziselwa ukuvavanya ubungakanani bomhlaza. I-Bone Scan: I-Bone scan isetyenziselwa ukujonga ukuba umhlaza unwenwele na emathanjeni. I-PET Scan: I-PET scan inokunceda ekuboneni iiseli zomhlaza kuwo wonke umzimba. I-Biopsy: I-biopsy ibandakanya ukususa isampuli encinci yethishu kwizintso okanye indawo ye-metastatic ukuze ihlolwe phantsi kwe-microscope. Oku kuqinisekisa ukuxilongwa kwe-RCC kwaye inceda ukumisela uhlobo oluthile lwe-RCC. Iinketho zoNyango lweMetastatic Renal Cell CarcinomaTreatment for I-metastatic renal cell carcinoma kuxhomekeke kwizinto eziliqela, kuquka ubungakanani bomhlaza, impilo yomguli, kunye neempawu ezithile zethumba. Iinketho zonyango eziqhelekileyo zibandakanya: Unyango oluJolisiweyo lwamachiza onyango olujoliswe kwiimolekyuli ezithile ezibandakanyekayo ekukhuleni kweeseli zomhlaza kunye nokuphila. La machiza anokunceda ukucothisa ukukhula komhlaza kunye nokuphucula amazinga okuphila. Unyango oluqhelekileyo ekujoliswe kulo lwe-mRCC lubandakanya: I-VEGF inhibitors (umzekelo, i-sunitinib, i-sorafenib, i- pazopanib, i-axitinib, i-cabozantinib): La machiza avala indlela ye-vascular endothelial growth factor (VEGF), ebalulekileyo ekubunjweni kwemithambo yegazi kumathumba. I-mTOR inhibitors (umzekelo, i-everolimus, i-temsirolimus): Ezi ziyobisi zivimbela i-mammalian target of rapamycin (mTOR) indlela, ebandakanyeka ekukhuleni kweeseli kunye ne-metabolism.I-ImmunotherapyImmunotherapy iziyobisi zinceda amajoni omzimba aqaphele kwaye ahlasele iiseli zomhlaza. La machiza abonise iziphumo ezithembisayo ekunyangeni i-mRCC. I-immunotherapies eqhelekileyo ye-mRCC ibandakanya: I-Checkpoint inhibitors (umzekelo, i-nivolumab, i-pembrolizumab, i-ipilimumab): Ezi ziyeza zivimba iiprotheni kwiiseli ezikhuselayo ezikhusela ekuhlaselweni kweeseli zomhlaza.I-SurgerySurgery ingaba yindlela yokususa intso (nephrectomy) okanye ukususa izicubu ze-metastatic kwezinye iindawo zomzimba. Oku kunokunceda ukukhulula iimpawu kunye nokuphucula umgangatho wobomi. I-Cytoreductive nephrectomy ibandakanya ukususa i-tumor yezintso eziphambili nokuba umhlaza usasazeke kwezinye iindawo zomzimba. Oku kunokuphucula ukusebenza kolunye unyango.Unyango lweRadiation TherapyRadiation isebenzisa imiqadi ene-eneji ephezulu ukubulala iiseli zomhlaza. Ingasetyenziselwa ukukhulula intlungu okanye ezinye iimpawu ezibangelwa yi-metastatic tumors, ngokukodwa emathanjeni okanye ebuchosheni.Izilingo zeClinicalIzilingo zeClinical zizifundo zophando ezivavanya unyango olutsha lomhlaza. Izigulane ezine I-metastatic renal cell carcinoma unokucinga ngokuthatha inxaxheba kulingo lwezonyango ukufikelela kunyango olucuthekileyo.I-Prognosis ye-Metastatic Renal Cell CarcinomaI-prognosis for I-metastatic renal cell carcinoma iyahluka ngokuxhomekeke kwizinto eziliqela, kuquka ubungakanani bomhlaza, impilo yesigulana ngokubanzi, kunye nendlela asabela ngayo kunyango. Ngokwembali, i-mRCC yayinoqikelelo olulambathayo, kodwa ukuqhubela phambili kunyango ekujoliswe kulo kunye nonyango lokhuselo lomzimba luphucule kakhulu iziphumo kwizigulana ezininzi. Izinto ezinokuchaphazela i-prognosis ziquka i-International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk score, eqwalasela izinto ezifana nexesha lokuxilonga ukuya kunyango, imeko yokusebenza, amanqanaba e-hemoglobin, amanqanaba e-calcium, i-neutrophil count, kunye ne-platelet count.Ukuphila ne-Metastatic Renal Cell CarcinomaUkuphila kunye I-metastatic renal cell carcinoma kunokuba lucelomngeni, ngokwasemzimbeni nangokweemvakalelo. Kubalulekile ukuba nenkqubo yenkxaso eyomeleleyo kwaye uthathe amanyathelo okulawula iimpawu kunye neziphumo ebezingalindelekanga zonyango. Oku kunokubandakanya: Ulawulo lweentlungu Inkxaso yesondlo Ukuzilolonga kunye nonyango lomzimba Ingcebiso okanye amaqela enkxaso Indima yeShandong Baofa Cancer Research InstituteAt. IZiko loPhando ngoMhlaza laseShandong Baofa, sizinikele ekunikeni ukhathalelo olubanzi kunye nolutsha lomhlaza. Sizimisele ukuqhubela phambili uphando lomhlaza kunye nokubonelela izigulana ngonyango olungcono kakhulu. Iqela lethu leengcali ze-oncologists ezinamava, oogqirha botyando, kunye nabasebenzi benkxaso basebenza kunye ukuphuhlisa izicwangciso zonyango zomntu ngamnye ngokugxila ekuphuculeni umgangatho wobomi kunye nokusinda ngokubanzi. Sizama ukunika uphuculo lwamva nje kunyango lomhlaza, kubandakanywa nonyango ekujoliswe kulo, amajoni omzimba, kunye novavanyo lweklinikhi.Izikhokelo zexesha elizayo kwiMetastatic Renal Cell Carcinoma Research Research I-metastatic renal cell carcinoma iyaqhuba, ngenjongo yokuphuhlisa unyango olutsha nolusebenza ngakumbi. Imimandla yangoku yophando ibandakanya: Ukuphuhliswa konyango olutsha olujoliswe kuyo kunye ne-immunotherapies Ukuchonga iimpawu ze-biomarkers ezinokuqikelela impendulo kunyango Ukuqonda iindlela zokuchasana nonyango olujoliswe kuyo kunye ne-immunotherapy Ukuphuhlisa izicwangciso ezintsha zokuthintela ukusasazeka kwe-RCCBy ukuqhubeka nokuqhubela phambili ukuqonda kwethu kwe-mRCC, sinokuphucula iziphumo zezigulane ezinesi sifo esinzima.